7/2
10:55 am
abt
Rating for ABT
Low
Report
Rating for ABT
6/4
10:07 am
abt
Abbott Laboratories (NYSE: ABT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $125.00 price target on the stock.
Low
Report
Abbott Laboratories (NYSE: ABT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $125.00 price target on the stock.
6/4
10:07 am
abt
Abbott Laboratories (NYSE: ABT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $125.00 price target on the stock.
Low
Report
Abbott Laboratories (NYSE: ABT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $125.00 price target on the stock.
6/4
09:34 am
abt
Rating for ABT
Low
Report
Rating for ABT
6/4
09:34 am
abt
Rating for ABT
Low
Report
Rating for ABT
5/30
07:37 am
abt
Rating for ABT
Low
Report
Rating for ABT
5/30
07:37 am
abt
Rating for ABT
Low
Report
Rating for ABT
5/30
07:37 am
abt
Rating for ABT
Low
Report
Rating for ABT
5/22
01:16 pm
abt
Rating for ABT
Low
Report
Rating for ABT
5/22
01:16 pm
abt
Rating for ABT
Low
Report
Rating for ABT